Hints and tips:
Related Special Reports
...Goudet, a prolific dealmaker who joined JAB from Mars over a decade ago, was instrumental in building up the group’s presence in the coffee category through a deal spree that led to the creation of JDE Peet...
...The S&P biotech index is trading about 50 per cent below its peak in February 2021....
...Dividends per share had risen just 10 cents since 2011, according to data from S&P Capital IQ....
...Under 28 U.S.C. section 1408, a company can file bankruptcy in any district where it has its domicile, principal place of business, or principal assets for 180 days prior to bankruptcy....
...London’s unfancied FTSE 100 index, which rose just 3.8 per cent this year against a 24 per cent jump in Wall Street’s S&P 500, was also home to high-street mainstay Marks and Spencer, which took the third...
...The stock bucked the wider pharma sell-off, rising 60 per cent last year. A price to forward earnings multiple of over 50 values the stock more like a tech company than a pharma group....
...The Granolas as a group have climbed 18 per cent over the past 12 months beating the Stoxx 600’s 7.5 per cent rise over the same period....
...University California, San Diego, for example, returned a leading 11 per cent in fiscal 2023 by virtue of its nearly one-third allocation to the S&P 500....
...Norman S Poser Professor Emeritus, Brooklyn Law School New York, NY, US...
...The new generation of diet drugs are one of the top trends on calls this year, going well beyond pharma/biotechs....
...Mars was also applauded by Galvanize. The US snacks and pet food company revamped its pay programme for its top 300 executives, who have a piece of their bonuses linked to emissions reduction goals....
...German pharma group Boehringer Ingelheim and Copenhagen-based Zealand Pharma said their weight-loss drug had achieved positive results in liver disease trials....
...to Mars....
...Robinson’s first hit novels Red Mars, Green Mars and Blue Mars, published between 1992 and 1996, surfed on “red planet fever”, which gripped space enthusiasts after US rovers revealed Mars to be slightly...
...The S&P 500 closed down almost 1 per cent with roughly nine in every 10 stocks losing ground....
...who started in international banking in Switzerland in the early 1970s, I always have to smile when I read an article that predicts that the era of Swiss franc appreciation is coming to an end (Markets...
...A once-popular fund, the SPDR S&P Biotech ETF, has lost 14 per cent of its value this year, falling 60 per cent from its highs....
...Just over a decade later I was bemoaning the Götterdämmerung of Big Pharma in the Lombard column....
...Martin Wolf ‘s column (“How to finance a faster shift to a better world”, Opinion, October 18) is right to underscore the urgency of better positioning the multilateral development banks to...
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
...High-grade pharma group Bristol Myers Squibb sold $13bn of debt on Wednesday....
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...Novo Nordisk’’s share price closed up 0.7 per cent to DKK1,311 ($190), giving the company a market capitalisation of $428bn. On Friday last week it had briefly dethroned LVMH....
...Communications Q1 Tuesday Bank of England chief economist Huw Pill speaks at the London campus of the University of Chicago, Booth School of Business EU, France, Germany, India, Italy, Japan, UK, US: S&...
International Edition